ES2060362T3 - Metodo para aumentar la fertilidad en los machos. - Google Patents

Metodo para aumentar la fertilidad en los machos.

Info

Publication number
ES2060362T3
ES2060362T3 ES91902935T ES91902935T ES2060362T3 ES 2060362 T3 ES2060362 T3 ES 2060362T3 ES 91902935 T ES91902935 T ES 91902935T ES 91902935 T ES91902935 T ES 91902935T ES 2060362 T3 ES2060362 T3 ES 2060362T3
Authority
ES
Spain
Prior art keywords
males
increase fertility
fertility
administration
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91902935T
Other languages
English (en)
Inventor
Kenneth M Attie
Jennie P Mather
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ES2060362T3 publication Critical patent/ES2060362T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Fats And Perfumes (AREA)
  • Steroid Compounds (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Paper (AREA)
  • Control Of Steam Boilers And Waste-Gas Boilers (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)

Abstract

SE FACILITA UN METODO PARA INCREMENTAR LA FERTILIDAD DE UN MAMIFERO MACHO QUE MUESTRA INSUFICIENCIA DEL EPITELIO GERMINAL QUE COMPRENDE LA ADMINISTRACION AL MAMIFERO DE UNA CANTIDAD EFICAZ DE ACTIVINA. PREFERIBLEMENTE, LA ADMINISTRACION SE EFECTUA EN EL TESTIS DEL MAMIFERO.
ES91902935T 1990-01-08 1991-01-04 Metodo para aumentar la fertilidad en los machos. Expired - Lifetime ES2060362T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/461,714 US5166190A (en) 1990-01-08 1990-01-08 Method for increasing fertility in males

Publications (1)

Publication Number Publication Date
ES2060362T3 true ES2060362T3 (es) 1994-11-16

Family

ID=23833655

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91902935T Expired - Lifetime ES2060362T3 (es) 1990-01-08 1991-01-04 Metodo para aumentar la fertilidad en los machos.

Country Status (10)

Country Link
US (1) US5166190A (es)
EP (1) EP0510073B1 (es)
JP (1) JPH05503701A (es)
AT (1) ATE92330T1 (es)
AU (1) AU634862B2 (es)
CA (1) CA2069442A1 (es)
DE (1) DE69100231T2 (es)
DK (1) DK0510073T3 (es)
ES (1) ES2060362T3 (es)
WO (1) WO1991010444A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
SE8901127D0 (sv) * 1989-03-31 1989-03-31 Aa H L Pousette Reagenssats och dess anvaending foer att bilda (spap-anti-spap) -immunkomplex samt diagnostiskt foerfarand vid vilket spap detekteras
US5102868A (en) * 1990-01-08 1992-04-07 Genentech, Inc. Method for inhibiting follicular maturation
US5304603A (en) * 1991-06-18 1994-04-19 The Population Council Leydig cell stimulator
KR100259827B1 (ko) 1991-11-04 2000-06-15 브루스 엠. 에이센, 토마스 제이 데스로저 재조합 골형태 형성 단백질 헤테로다이머, 그 조성물 및 사용방법
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
EP0698094B1 (en) 1993-05-12 2004-02-04 Genetics Institute, LLC Bmp-11 compositions
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
EP0733109B9 (en) 1993-12-07 2006-07-05 Genetics Institute, LLC Bmp-12, bmp-13 and tendon-inducing compositions thereof
US5658876A (en) * 1994-04-28 1997-08-19 The General Hospital Corporation Activin antagonists as novel contraceptives
US5545616A (en) * 1994-09-22 1996-08-13 Genentech, Inc. Method for predicting and/or preventing preterm labor
CA2137219C (en) * 1994-12-02 1997-10-21 Salva Gideon Extract for improving male sperm count and use as anti-microbial or anti-inflammatory agent
CA2247502A1 (en) * 1996-02-28 1997-09-04 Vanderbilt University Compositions and methods of making embryonic stem cells
DE19641378C1 (de) * 1996-09-27 1998-04-02 Ihf Inst Fuer Hormon Und Fortp Diagnosehilfe sowie Verfahren zum Nachweis der Trächtigkeit von Wiederkäuern
AUPO439396A0 (en) * 1996-12-24 1997-01-23 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment and prophylaxis
AUPO550897A0 (en) 1997-03-06 1997-03-27 Luminis Pty Limited Treatment and diagnosis of an infertility condition
AU722150B2 (en) * 1997-03-06 2000-07-20 University Of Adelaide, The Treatment and diagnosis of infertility using TGFbeta or activin
EP1100872A1 (en) * 1998-07-24 2001-05-23 Carnegie Institution Of Washington Method for maintenance and propagation of germline stem cells using members of the tgf-beta family of growth factors
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
EP1223990B1 (en) 1999-10-15 2004-07-28 Genetics Institute, LLC Formulations of hyaluronic acid for delivery of osteogenic proteins
ATE321551T1 (de) * 2000-07-10 2006-04-15 Hormos Medical Ltd Methoden zur behandlung des kryptorchysmus
TWI329129B (en) 2001-02-08 2010-08-21 Wyeth Corp Modified and stabilized gdf propeptides and uses thereof
WO2002094987A2 (en) * 2001-05-18 2002-11-28 Cornell Research Foundation, Inc. In vitro production of haploid germ cells
US7226587B2 (en) 2001-06-01 2007-06-05 Wyeth Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
RU2200012C1 (ru) * 2002-03-22 2003-03-10 Артюхин Александр Александрович Способ лечения больных с нарушением мужской половой функции методом трансплантации
RU2200010C1 (ru) * 2002-03-22 2003-03-10 Артюхин Александр Александрович Способ лечения больных с нарушением мужской половой функции методом трансплантации
US7345073B2 (en) 2003-02-07 2008-03-18 Hormos Medical Ltd. Method for treating cryptorchidism
TW200518767A (en) 2003-09-12 2005-06-16 Wyeth Corp Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
DE102005033972A1 (de) 2005-07-20 2007-01-25 Dürr Systems GmbH Beschichtungsverfahren und zugehörige Beschichtungseinrichtung
WO2013131979A2 (en) 2012-03-06 2013-09-12 Kernan Colm A communication system for text messages

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734398A (en) * 1983-03-15 1988-03-29 University Of Southern California Follicular regulating protein
US4764502A (en) * 1983-03-15 1988-08-16 University Of Southern California Intragonadal regulatory protein
CA1268417A (en) * 1984-10-11 1990-05-01 Gere S. Dizerega Intragonadal regulatory protein
US4798885A (en) * 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom
US4997815A (en) * 1988-11-01 1991-03-05 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin

Also Published As

Publication number Publication date
EP0510073B1 (en) 1993-08-04
AU634862B2 (en) 1993-03-04
AU7150491A (en) 1991-08-05
ATE92330T1 (de) 1993-08-15
US5166190A (en) 1992-11-24
CA2069442A1 (en) 1991-07-09
DE69100231T2 (de) 1994-01-13
EP0510073A1 (en) 1992-10-28
DK0510073T3 (da) 1993-11-29
DE69100231D1 (de) 1993-09-09
WO1991010444A1 (en) 1991-07-25
JPH05503701A (ja) 1993-06-17

Similar Documents

Publication Publication Date Title
ATE92330T1 (de) Verfahren zur erhoehung der fertilitaet bei maennchen.
JPS5360651A (en) Semiconductor laser with optical fibers
IT1111874B (it) Pezzo intermedio con un detettore di luce per un collegamento disimpegnabile ad innesto,impiegato per il collegamento di una fibra per la conduzione di luce con una sorgente di luce a semiconduttore
ES2071227T3 (es) Composicion para gotas para los ojos.
ES2071607T3 (es) Cubierta de empalme de fibra optica.
DE3279539D1 (en) Multimode fiber optic rotation sensor
AU3345284A (en) Fiber optic amplifier
GR3025787T3 (en) Optical fibre with fluorescent additive
ES2173892T3 (es) Procedimiento para aumentar el indice spf compuestos adecuados para aumentar el indice spf de fibras o generos.
ES2046889T3 (es) Metodo para inhibicion de la maduracion folicular.
GB8923122D0 (en) Light fittings
ES2039461T3 (es) Alimentacion de fibras opticas.
ES2103575T3 (es) Procedimiento para la preparacion de 9-(2-hidroxi)-etoximetil-guanina.
ES2089910T3 (es) Acabado antiestatico para fibras teñibles de poli(isoftalamida de m-fenileno) que contienen un agente tensoactivo.
JPS51149034A (en) Propagation mode converting optical coupler
JPS5576316A (en) Connection structure of optical fiber
ES2030846T3 (es) Composicion hibrida de combustible diesel.
ES2053561T3 (es) Metodos y composiciones para inhibir cataratas secundarias.
JPS5524460A (en) Semiconductor laser system
GB871382A (en) Improvements in or relating to methods of manufacturing waveguide structures
JPS5419762A (en) Optical coupling method
ES2081470T3 (es) Composiciones y metodos para aliviar los sintomas menopausicos.
ES2053843T3 (es) Detergentes anionicos liquidos, estables al almacenaje, conteniendo derivados anfoteros de diestirilo.
JPS57171307A (en) Optical fiber coupler connecting light emitter and optical fiber
JPS5334538A (en) Photo coupler

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 510073

Country of ref document: ES